thrombolytic efficacy with respect to patency rates is highest after intravenous application of so-called fibrin-selective thrombolytic agents ( rt-pa ) and apsac ( 71 % and 73 % ) , intracoronary application of streptokinase ( 69 % ) , and primary percutaneous transluminal coronary angioplasty ( 88 % ) .
C0078956
apsac
C0038418
streptokinase